Terms: = Head and neck cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Diagnosis
5 results:
1. Lipidome-based rapid diagnosis with machine learning for detection of TGF-β signalling activated area in head and neck cancer.
Ishii H; Saitoh M; Sakamoto K; Sakamoto K; Saigusa D; Kasai H; Ashizawa K; Miyazawa K; Takeda S; Masuyama K; Yoshimura K
Br J Cancer; 2020 Mar; 122(7):995-1004. PubMed ID: 32020064
[TBL] [Abstract] [Full Text] [Related]
2. Dynamic profile of differentiated thyroid cancer in male and female patients with thyroidectomy during 2000-2013 in China: a retrospective study.
Yan HX; Pang P; Wang FL; Tian W; Luo YK; Huang W; Yang GQ; Jin N; Zang L; Du J; Ba JM; Dou JT; Mu YM; Lyu ZH
Sci Rep; 2017 Nov; 7(1):15832. PubMed ID: 29158505
[TBL] [Abstract] [Full Text] [Related]
3. Enhanced Expression of miR-425 Promotes Esophageal Squamous Cell Carcinoma Tumorigenesis by Targeting smad2.
Liu L; Zhao Z; Zhou W; Fan X; Zhan Q; Song Y
J Genet Genomics; 2015 Nov; 42(11):601-611. PubMed ID: 26674378
[TBL] [Abstract] [Full Text] [Related]
4. A retrospective study of head and neck re-irradiation for patients with recurrent or second primary head and neck cancer: the McGill University experience.
Al-Wassia R; Vakilian S; Holly C; Sultanem K; Shenouda G
J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):31. PubMed ID: 26330008
[TBL] [Abstract] [Full Text] [Related]
5. Disruption of transforming growth factor-beta signaling by five frequently methylated genes leads to head and neck squamous cell carcinoma pathogenesis.
Bennett KL; Romigh T; Eng C
Cancer Res; 2009 Dec; 69(24):9301-5. PubMed ID: 19934318
[TBL] [Abstract] [Full Text] [Related]
